Epistaxis
Epistaxis
Epistaxis
The nose has a rich vascular supply, with substantial contributions from the internal carotid
artery (ICA) and the external carotid artery (ECA).
The ECA system supplies blood to the nose via the facial and internal maxillary arteries. The
superior labial artery is one of the terminal branches of the facial artery. This artery subsequently
contributes to the blood supply of the anterior nasal floor and anterior septum through a septal
branch.
The internal maxillary artery enters the pterygomaxillary fossa and divides into 6 branches:
posterior superior alveolar, descending palatine, infraorbital, sphenopalatine, pterygoid canal,
and pharyngeal.
The descending palatine artery descends through the greater palatine canal and supplies the
lateral nasal wall. It then returns to the nose via a branch in the incisive foramen to provide blood
to the anterior septum. The sphenopalatine artery enters the nose near the posterior attachment of
the middle turbinate to supply the lateral nasal wall. It also gives off a branch to provide blood
supply to the septum.
The ICA contributes to nasal vascularity through the ophthalmic artery. This artery enters the
bony orbit via the superior orbital fissure and divides into several branches. The posterior
ethmoid artery exits the orbit through the posterior ethmoid foramen, located 2-9 mm anterior to
the optic canal. The larger anterior ethmoid artery leaves the orbit through the anterior ethmoid
foramen.
The anterior and posterior ethmoid arteries cross the ethmoid roof to enter the anterior cranial
fossa and then descend into the nasal cavity through the cribriform plate. Here, they divide into
lateral and septal branches to supply the lateral nasal wall and the septum.
The Kiesselbach plexus, or Littles area, is an anastomotic network of vessels located on the
anterior cartilaginous septum. It receives blood supply from both the ICA and the ECA.[6] Many
of the arteries supplying the septum have anastomotic connections at this site.
Bleeding typically occurs when the mucosa is eroded and vessels become exposed and
subsequently break.
More than 90% of bleeds occur anteriorly and arise from Littles area, where the Kiesselbach
plexus forms on the septum.[7, 8] The Kiesselbach plexus is where vessels from both the ICA
(anterior and posterior ethmoid arteries) and the ECA (sphenopalatine and branches of the
internal maxillary arteries) converge. These capillary or venous bleeds provide a constant ooze,
rather than the profuse pumping of blood observed from an arterial origin. Anterior bleeding may
also originate anterior to the inferior turbinate.
Posterior bleeds arise further back in the nasal cavity, are usually more profuse, and are often of
arterial origin (eg, from branches of the sphenopalatine artery in the posterior nasal cavity or
nasopharynx). A posterior source presents a greater risk of airway compromise, aspiration of
blood, and greater difficulty controlling bleeding.
Causes of epistaxis can be divided into local causes (eg, trauma, mucosal irritation, septal
abnormality, inflammatory diseases, tumors), systemic causes (eg, blood dyscrasias,
arteriosclerosis, hereditary hemorrhagic telangiectasia), and idiopathic causes. Local trauma is
the most common cause, followed by facial trauma, foreign bodies, nasal or sinus infections, and
prolonged inhalation of dry air. Children usually present with epistaxis due to local irritation or
recent upper respiratory infection (URI).
Trauma
Self-induced trauma from repeated nasal picking can cause anterior septal mucosal ulceration
and bleeding. This scenario is frequently observed in young children. Nasal foreign bodies that
cause local trauma (eg, nasogastric and nasotracheal tubes) can be responsible for rare cases of
epistaxis.
Acute facial and nasal trauma commonly leads to epistaxis. If the bleeding is from minor
mucosal laceration, it is usually limited. However, extensive facial trauma can result in severe
bleeding requiring nasal packing. In these patients, delayed epistaxis may signal the presence of
a traumatic aneurysm.
Patients undergoing nasal surgery should be warned of the potential for epistaxis. As with nasal
trauma, bleeding can range from minor (due to mucosal laceration) to severe (due to transection
of a major vessel).
Dry weather
Low humidity may lead to mucosal irritation. Epistaxis is more prevalent in dry climates and
during cold weather due to the dehumidification of the nasal mucosa by home heating systems.
Drugs
Topical nasal drugs such as antihistamines and corticosteroids may cause mucosal irritation.
Especially when applied directly to the nasal septum instead of the lateral walls, they may cause
mild epistaxis. Medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) are also
frequently involved.
Septal abnormality
Septal deviations (deviated nasal septum) and spurs may disrupt the normal nasal airflow,
leading to dryness and epistaxis. The bleeding sites are usually located anterior to the spurs in
most patients. The edges of septal perforations frequently harbor crusting and are common
sources of epistaxis.
Inflammation
Bacterial, viral, and allergic rhinosinusitis causes mucosal inflammation and may lead to
epistaxis. Bleeding in these cases is usually minor and frequently manifests as blood-streaked
nasal discharge.
Granulomatosis diseases such as sarcoidosis, Wegener granulomatosis, tuberculosis, syphilis, and
rhinoscleroma often lead to crusting and friable mucosa and may be a cause of recurrent
epistaxis.
Young infants with gastroesophageal reflux into the nose may have epistaxis secondary to
inflammation.
Tumors
Benign and malignant tumors can manifest as epistaxis. Affected patients may also present with
signs and symptoms of nasal obstruction and rhinosinusitis, often unilateral.
Intranasal rhabdomyosarcoma, although rare, often begins in the nasal, orbital, or sinus area in
children. Juvenile nasal angiofibroma in adolescent males may cause severe nasal bleeding as the
initial symptom.
Blood dyscrasias
Congenital coagulopathies should be suspected in individuals with a positive family history, easy
bruising, or prolonged bleeding from minor trauma or surgery. Examples of congenital bleeding
disorders include hemophilia and von Willebrand disease.[6]
Acquired coagulopathies can be primary (due to the diseases) or secondary (due to their
treatments). Among the more common acquired coagulopathies are thrombocytopenia and liver
disease with its consequential reduction in coagulation factors. Even in the absence of liver
disease, alcoholism has also been associated with coagulopathy and epistaxis. Oral
anticoagulants predispose to epistaxis.
Vascular abnormalities
Arteriosclerotic vascular disease is considered a reason for the higher prevalence of epistaxis in
elderly individuals.
Hereditary hemorrhagic telangiectasia (HHT; also known as Osler-Weber-Rendu syndrome) is an
autosomal dominant disease associated with recurrent bleeding from vascular anomalies. The
condition can affect vessels ranging from capillaries to arteries, leading to the formation of
telangiectasias and arteriovenous malformations. Pathologic examination of these lesions reveals
a lack of elastic or muscular tissue in the vessel wall. As a result, bleeding can occur easily from
minor trauma and tends not to stop spontaneously.
Various organ systems such as the respiratory, gastrointestinal, and genitourinary systems may be
involved. The epistaxis in these individuals is variable in severity but is almost universally
recurrent.
Other vascular abnormalities that predispose to epistaxis include vascular neoplasms, aneurysms,
and endometriosis.
Migraine
Children with migraine headaches have a higher incidence of recurrent epistaxis than children
without the disease.[9] The Kiesselbach plexus, which is part of the trigeminovascular system, has
been implicated in the pathogenesis of migraine.[10]
Hypertension
The relationship between hypertension and epistaxis is often misunderstood. Patients with
epistaxis commonly present with an elevated blood pressure. Epistaxis is more common in
hypertensive patients, perhaps owing to vascular fragility from long-standing disease.
Hypertension, however, is rarely a direct cause of epistaxis. More commonly, epistaxis and the
associated anxiety cause an acute elevation of blood pressure. Therapy, therefore, should be
focused on controlling hemorrhage and reducing anxiety as primary means of blood pressure
reduction.
Excessive coughing causing nasal venous hypertension may be observed in pertussis or cystic
fibrosis.
Idiopathic causes
The cause of epistaxis is not always readily identifiable. Approximately 10% of patients with
epistaxis have no identifiable causes even after a thorough evaluation.[11]
Frequency of epistaxis is difficult to determine because most episodes resolve with self-treatment
and, therefore, are not reported.[12] However, when multiple sources are reviewed, the lifelong
incidence of epistaxis in the general population is about 60%, with fewer than 10% seeking
medical attention.[6, 13, 12]
The age distribution is bimodal, with peaks in young children (2-10 y) and older individuals (5080 y). Epistaxis is unusual in infants in the absence of a coagulopathy or nasal pathology (eg,
choanal atresia, neoplasm). Local trauma (eg, nose picking) does not occur until later in the
toddler years. Older children and adolescents also have a less frequent incidence. Consider
cocaine abuse in adolescent patients.
Prevalence of epistaxis tends to be higher in males (58%) than in females (42%)
For most of the general population, epistaxis is merely a nuisance. However, the problem can
occasionally be life-threatening, especially in elderly patients and in those patients with
underlying medical problems. Fortunately, mortality is rare and is usually due to complications
from hypovolemia, with severe hemorrhage or underlying disease states.
Overall, the prognosis is good but variable; with proper treatment, it is excellent. When adequate
supportive care is provided and underlying medical problems are controlled, most patients are
unlikely to experience any rebleeding. Others may have minor recurrences that resolve
spontaneously or with minimal self-treatment. A small percentage of patients may require
repacking or more aggressive treatments.
Patients with epistaxis that occurs from dry membranes or minor trauma do well, with no longterm effects. Patients with HHT tend to have multiple recurrences regardless of the treatment
modality. Patients with bleeding from a hematologic problem or cancer have a variable
prognosis. Patients who have undergone nasal packing are subject to increased morbidity.
Posterior packing can potentially cause airway compromise and respiratory depression. Packing
in any location may lead to infection.
For patient education resources, see the Breaks, Fractures, and Dislocations Center, as well as
Broken Nose.
The following precautions should be imparted to the patient:
The following simple instructions for self-treatment for minor epistaxis should be provided:
local tissue necrosis. Severe complications (eg, nasal stenosis) can result from batteries.
Removal is a priority; removing the batteries within 4 hours of insertion is best.
In addition to obtaining a head and neck history with an emphasis on nasal symptoms,
elicit a general medical history concerning relevant medical conditions, current
medications, and smoking and drinking habits.
Inquire about previous epistaxis, hypertension, hepatic or other systemic disease, easy
bruising, or prolonged bleeding after minor surgical procedures. A history of frequent
recurrent nosebleeds, easy bruising, or other bleeding episodes should make the clinician
suspicious of a systemic cause and prompt a hematologic workup. Obtain any family
history of bleeding disorders or leukemia.
Children with severe epistaxis are more likely to have required nasal cauterization, an
underlying coagulopathy, a positive family history of bleeding, and anemia. Although
unusual, children with bleeding disorders (eg, von Willebrand disease) can occasionally
have normal coagulation profiles. More than 1 sample may be required to notice the
abnormality due to biologic variability throughout the day.
Use of medicationsespecially aspirin, NSAIDs, warfarin, heparin, ticlopidine, and
dipyridamoleshould be documented, as these not only predispose to epistaxis but make
treatment more difficult. Particularly in children, include investigation of suspicion of
accidental ingestion (eg, accidental ingestion of rat poison in toddlers).
Before evaluating a patient with epistaxis, have sufficient illumination, adequate suction,
all the necessary topical medications, and cauterization and packing materials ready.
Remove all packings, even though bleeding may not be active. The importance of
obtaining adequate anesthesia and vasoconstriction if time permits cannot be
overemphasized. A comfortable patient tends to be more cooperative, allowing for better
examination and more effective treatment.
Perform a thorough and methodical examination of the nasal cavity. Blowing the nose
decreases the effects of local fibrinolysis and removes clots, permitting a better
examination. Application of a vasoconstrictor (eg, 0.05% oxymetazoline) before the
examination may reduce hemorrhage and help to pinpoint the precise bleeding site. A
topical anesthetic (eg, 4% aqueous lidocaine) reduces pain associated with the
examination and nasal packing. Clots are then suctioned out to permit a thorough
examination.
Gently insert a nasal speculum (see the image below) and spread the naris vertically.
Begin the examination with inspection, looking specifically for any obvious bleeding site
on the septum that may be amenable to direct pressure or cautery. This permits
visualization of most anterior bleeding sources. Anterior bleeds from the nasal septum are
most common type, and the site can frequently be identified if bleeding is active.
Nasal speculum.
Sinusitis
Septal hematoma/perforation
Vasovagal episode
Balloon migration
Aspiration
Recurrent epistaxis in children could be caused by a foreign body, especially if the nosebleeds
are accompanied by symptoms of unilateral nasal congestion and purulent rhinorrhea. Delayed
epistaxis in a trauma patient may signal the presence of a traumatic aneurysm.
Other conditions to be considered include the following:
Chemical irritants
Hepatic failure
Leukemia
Thrombocytopenia
Heparin toxicity
Ticlopidine toxicity
Dipyridamole toxicity
Trauma
Tumor
Differential Diagnoses
Allergic Rhinitis
Rodenticide Toxicity
Sinusitis Imaging
Type A Hemophilia
Type B Hemophilia
For the most part, laboratory studies are not needed or helpful for first-time nosebleeds or
infrequent recurrences with a good history of nose picking or trauma to the nose.
However, they are recommended if major bleeding is present or if a coagulopathy is
suspected.
Laboratory tests to evaluate the patients condition and underlying medical problems may
be ordered depending on the clinical picture at the time of presentation. If the bleeding is
minor and not recurrent, then a laboratory evaluation may not be needed.
If a history of persistent heavy bleeding is present, obtain a hematocrit count and type and
cross-match. If a history of recurrent epistaxis, a platelet disorder, or neoplasia is present,
obtain a complete blood count (CBC) with differential. The bleeding time is an excellent
screening test if suspicion of a bleeding disorder is present. Obtain the international
normalized ratio (INR)/prothrombin time (PT) if the patient is taking warfarin or if liver
disease is suspected. Obtain the activated partial thromboplastin time (aPTT) as
necessary.
Direct visualization with a good directed light source, a nasal speculum, and nasal suction
should be sufficient in most patients. However, computed tomography (CT) scanning,
magnetic resonance imaging (MRI) or both may be indicated to evaluate the surgical
anatomy and to determine the presence and extent of rhinosinusitis, foreign bodies, and
neoplasms. Nasopharyngoscopy may also be performed if a tumor is the suspected cause
of bleeding.
Sinus films are rarely indicated for a nosebleed. Angiography is rarely indicated.
When medical attention is needed for epistaxis, it is usually because of the problem is either
recurrent or severe. Treatment depends on the clinical picture, the experience of the treating
physician, and the availability of ancillary services.
In most patients with epistaxis, the bleeding responds to cauterization, nasal packing, or both.
For those who have recurrent or severe bleeding for which medical therapy has failed, various
surgical options are available. After surgery or embolization, patients should be closely observed
for any complications or signs of rebleeding.
Medical approaches to the treatment of epistaxis may include the following:
Adequate pain control in patients with nasal packing, especially in those with posterior
packing (However, the need of adequate pain control has to be balanced with the concern
over hypoventilation in the patient with posterior pack.)
Oral and topical antibiotics to prevent rhinosinusitis and possibly toxic shock syndrome
Also see Anterior Epistaxis Nasal Pack, Posterior Epistaxis Nasal Pack, and Surgery for
Pediatric Epistaxis.
Most patients with epistaxis who seek medical attention are likely to be treated with
cauterization, anterior packing, or both. Those with severe or recalcitrant bleeding
may need posterior packing, arterial ligation, or embolization. Pharmacotherapy
plays only a supportive role in treating the patient with epistaxis.
Class Summary
Topical vasoconstrictors act on alpha-adrenergic receptors in the nasal mucosa, causing vessels
to constrict.
View full drug information
Oxymetazoline 0.05% (Afrin)
When anesthetics are used concomitantly with vasoconstrictors, their anesthetic effect is
prolonged and the pain threshold increased.
View full drug information
Lidocaine 4% (Xylocaine)
Lidocaine decreases permeability to sodium ions in neuronal membranes. This results in the
inhibition of depolarization, blocking the transmission of nerve impulses.
Lidocaine can be used in combination with oxymetazoline 0.05% to provide effective nasal
anesthesia and vasoconstriction.
Class Summary
Antibiotic ointments help prevent local infection and provide local moisturization.
View full drug information
Mupirocin ointment 2% (Bactroban nasal)
Mupirocin ointment inhibits bacterial growth by inhibiting RNA and protein synthesis. It is a
compounded medication.
Class Summary
Cauterizing agents coagulate cellular proteins, which can in turn reduce bleeding.
View full drug information
Silver nitrate
Silver nitrate coagulates cellular protein and removes granulation tissue. It also has antibacterial
effects.